1 month Q2 EPS Estimates for AngioDynamics Reduced by Zacks ResearchMarketBeat
AngioDynamics, Inc. (NASDAQ:ANGO – Free Report) – Stock analysts at Zacks Research lowered their Q2 2025 earnings estimates for AngioDynamics in a research report issued on Wednesday, October 23rd. Zacks Research analyst D. Dey now forecasts that th…
Earnings · Nasdaq 100 · Science
X